TEK tyrosine kinase
TEK Tyrosine Kinase is a protein encoded by the TEK gene in humans. It is also known as TIE2, a member of the tyrosine kinase family of proteins. This protein plays a crucial role in angiogenesis and vasculogenesis, the processes by which new blood vessels form from pre-existing ones.
Structure[edit]
The TEK Tyrosine Kinase is a receptor tyrosine kinase that contains a epidermal growth factor homology domain and three immunoglobulin-like C2-type domains at the extracellular region. The intracellular region contains two tyrosine kinase domains, indicating its role in signal transduction.
Function[edit]
TEK Tyrosine Kinase is predominantly expressed in endothelial cells and is essential for blood vessel maturation, stability, and remodeling. It is activated by binding to angiopoietin ligands, leading to the phosphorylation of tyrosine residues. This activation triggers a series of downstream signaling pathways, including the PI3K/AKT pathway, which promotes cell survival, and the MAPK pathway, which regulates cell proliferation and differentiation.
Clinical Significance[edit]
Mutations in the TEK gene are associated with several vascular anomalies, including venous malformations and cutaneomucosal venous malformations. In addition, TEK signaling is implicated in various types of cancers, including colorectal cancer, breast cancer, and lung cancer. Inhibitors of TEK Tyrosine Kinase are being explored as potential therapeutic agents in these diseases.
See Also[edit]
- Tyrosine kinase
- Angiogenesis
- Vasculogenesis
- Endothelial cells
- Angiopoietin
- PI3K/AKT pathway
- MAPK pathway
- Venous malformations
- Cutaneomucosal venous malformations
- Colorectal cancer
- Breast cancer
- Lung cancer
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian